New treatment for multiple sclerosis: Cambridge University translates research at the bench into a drug at the bedside
14 November 2011Phase III clinical trials for new MS drug very positive.
Research
Phase III clinical trials for new MS drug very positive.
The discovery by scientists in Cambridge and Alberta of a fifth adaptor protein – a tiny and vital component of many cells –will lay the...
Clare Holtham (1948-2010) had a huge enthusiasm for learning. After a troubled childhood, which led to a spell of homelessness, she became an intrepid traveller...
Don’t write off the unions yet – a new study reveals how trade unions are adapting to 21st century pressures in an effort to reclaim...
As we approach Remembrance Day, a Cambridge University project that looks at the role of memorials in conflict-torn communities is drawing to a close. By...
Ancient manuscripts that hold important clues to India’s intellectual and religious traditions will be the focus of a new study.
A team of Cambridge linguists has embarked on an ambitious project to identify how the languages of the world are built – from Inuit Yupik...
Seven Cambridge scientists have been appointed University Research Fellows (URFs) for 2011 by The Royal Society, the UK’s national academy of science.
The Dorothy Hodgkin Fellowship scheme supports excellent scientists and engineers at an early stage of their career.
Islanders: The Pacific in the Age of Empire tells the story of the Pacific Islanders and their early interactions with Western travellers from the viewpoint...